Boston Biomedical Associates plans to relocate to Marlborough

The following is a release from the Marlborough Economic Development Corporation

After more than a decade in business, Boston Biomedical Associates (BBA) is set to join one of Massachusetts most-thriving biotech communities the City of Marlborough.

The biotech product consultants owner and president Dr. Lauren Baker made the announcement today at a regional industry networking event, organized by the Massachusetts Biotechnology Council (MassBio).

Speaking to more than 100 members of the regions life sciences community, Baker said that BBA expects to relocate its Northborough headquarters to Marlborough in April 2014. The company will take up 17,000 sq.ft. of the second floor of 100 Crowley Drive, just off of Fitchburg Street and the I-290 Connector.

“Boston Biomedical Associates is extremely pleased to announce our relocation to the City of Marlborough and 100 Crowley Drive,” said Baker. “We chose Marlborough as our new home because this community has a strong reputation of supporting the biotech industry and healthcare companies like ours, and we want to be a part of such a dynamic working environment.”

BBA, a MassBio member, will be moving its 52 Massachusetts-based employees upstairs from the corporate headquarters of Park Place International, a healthcare IT services provider with offices across the U.S. and 45 employees in Marlborough.

“I’m pleased that my vision for this building as a local center for the biotech, healthcare and hi-tech industries is taking shape,” said Jon Delli Priscoli, CEO of First Colony Development (FCD), which built and owns the five-year-old building. “I want to welcome Boston Biomedical Associates to Crowley Drive, where they will join our first floor tenants, Park Place International. This new move further strengthens Marlborough’s position as a cluster for the life sciences industry. That’s why I think it is very fitting, and it is my honor, to host MassBio’s Regional Mixer at our state-of-the-art facility.

The building’s location made it an ideal host for the MassBio Regional Mixer, which was sponsored by the Marlborough Economic Development Corporation (MEDC), BBA and FCD. Massachusetts State Representative Danielle Gregoire, Marlborough Mayor Arthur Vigeant, and MassBio President and CEO Robert K. Coughlin were among the more than 100 people in attendance.

“Massachusetts has been walking the walk on job creation and scientific innovation, and the continued expansion of the biotech industry is proof of that,” said Representative Gregoire. “As our economy continues to recover we, as partners in government, must support growth opportunity in any manner possible and celebrate achievement. We welcome Boston Biomedical Associates and look forward to working with them to ensure the best of our resources are available to their employees, as they begin this pivotal expansion.”

In addition to welcoming BBA to its new home, the MassBio Mixer was intended to showcase the I-495 and Marlborough region as a great place for biotech companies to do business.

“Our latest statistics show life sciences companies continue to expand throughout Massachusetts, bringing good jobs and economic activity to municipalities across the Commonwealth,” said Coughlin. “The City of Marlborough and its elected and business leaders have made all the right moves to position the city as a destination for the industry, and we are excited to see Boston Biomedical Associates recognize that effort and join the community. We will continue to support the growth of the 495 belt as a life sciences hub.”

In December 2012, MassBio upgraded the City of Marlborough to its highest rating of Platinum BioReady® Community, in recognition of the city’s unwavering commitment to foster and host biotechnology companies. In May this year, MassBio publically identified Marlborough as a growing hub for life sciences companies.

“We have set a goal for Marlborough to become the place to be for biotechnology companies,” said Mayor Vigeant, “and we are slowly but surely achieving this goal. We are proud to say that we are creating a dedicated life sciences community by attracting companies of all sizes and specialties. So, while we have larger, nationally recognized companies, like Boston Scientific and Quest Diagnostics, we are also nurturing and supporting the smaller innovators, who are at the heart of this fast-growing industry.”